Adenosine A3 Receptor antibody (AA 269-318)
-
- Target See all Adenosine A3 Receptor (ADORA3) Antibodies
- Adenosine A3 Receptor (ADORA3)
-
Binding Specificity
- AA 269-318
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This Adenosine A3 Receptor antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Specificity
-
ADORA3 Antibody detects endogenous levels of total ADORA3 protein.
- Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
- Purity
- > 95 %
- Immunogen
- The antiserum was produced against synthesized peptide derived from human ADORA3.
- Isotype
- IgG
- Top Product
- Discover our top product ADORA3 Primary Antibody
-
-
- Application Notes
- WB: 1:500~1:1000 IF: 1:100~1:500 ELISA: 1:5000
- Comment
-
Unigene-Number: Hs.281342 (NCBI Gene Symbol: ADORA3)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Stable at -20°C for at least 1 year.
- Expiry Date
- 12 months
-
- Target
- Adenosine A3 Receptor (ADORA3)
- Alternative Name
- ADORA3 (ADORA3 Products)
- Synonyms
- A3AR antibody, AD026 antibody, bA552M11.5 antibody, ADORA3 antibody, 1700001D09Rik antibody, 4930578J19Rik antibody, A3R antibody, AA3R antibody, ARA3 antibody, Gpcr2 antibody, adenosine A3 receptor antibody, adenosine receptor A3 antibody, ADORA3 antibody, Adora3 antibody, LOC100603318 antibody
- Background
-
Synonyms: Adenosine A3 receptor, ADORA3,
NCBI Gene Symbol: ADORA3
- Molecular Weight
- 36 kDa
- Gene ID
- 140
- OMIM
- 600445
- UniProt
- P33765
- Pathways
- Hormone Transport, cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-